Single User License
INR 100155
Site License
INR 200310
Corporate User License
INR 300465

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Imaxio SA-Product Pipeline Review-2015

Imaxio SA-Product Pipeline Review-2015

  Request for Sample Report

Executive Summary

Imaxio SA-Product Pipeline Review-2015


Global Markets Direct's, 'Imaxio SA-Product Pipeline Review-2015', provides an overview of the Imaxio SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Imaxio SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Imaxio SA including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Imaxio SA's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Imaxio SA's pipeline products

Reasons To Buy

Evaluate Imaxio SA's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Imaxio SA in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Imaxio SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Imaxio SA and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Imaxio SA

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Imaxio SA and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Imaxio SA Snapshot 4

Imaxio SA Overview 4

Key Information 4

Key Facts 4

Imaxio SA-Research and Development Overview 5

Key Therapeutic Areas 5

Imaxio SA-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Imaxio SA-Pipeline Products Glance 9

Imaxio SA-Clinical Stage Pipeline Products 9

Phase I Products/Combination Treatment Modalities 9

Imaxio SA-Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

Discovery Products/Combination Treatment Modalities 11

Imaxio SA-Drug Profiles 12

IMX-313-TB 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

IMX-313-ML 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

IMX-313-SA 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

IMX-313-IF 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Imaxio SA-Pipeline Analysis 16

Imaxio SA-Pipeline Products by Target 16

Imaxio SA-Pipeline Products by Route of Administration 17

Imaxio SA-Pipeline Products by Molecule Type 18

Imaxio SA-Recent Pipeline Updates 19

Imaxio SA-Dormant Projects 20

Imaxio SA-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Appendix 22

Methodology 22

Coverage 22

Secondary Research 22

Primary Research 22

Expert Panel Validation 22

Contact Us 22

Disclaimer 23

List of Tables

Imaxio SA, Key Information 4

Imaxio SA, Key Facts 4

Imaxio SA-Pipeline by Indication, 2015 6

Imaxio SA-Pipeline by Stage of Development, 2015 7

Imaxio SA-Monotherapy Products in Pipeline, 2015 8

Imaxio SA-Phase I, 2015 9

Imaxio SA-Preclinical, 2015 10

Imaxio SA-Discovery, 2015 11

Imaxio SA-Pipeline by Target, 2015 16

Imaxio SA-Pipeline by Route of Administration, 2015 17

Imaxio SA-Pipeline by Molecule Type, 2015 18

Imaxio SA-Recent Pipeline Updates, 2015 19

Imaxio SA-Dormant Developmental Projects,2015 20

Imaxio SA, Subsidiaries 21

List of Figures

Imaxio SA-Pipeline by Top 10 Indication, 2015 6

Imaxio SA-Pipeline by Stage of Development, 2015 7

Imaxio SA-Monotherapy Products in Pipeline, 2015 8

Imaxio SA-Pipeline by Top 10 Molecule Type, 2015 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Imaxio SA; Imaxio SA - Key Therapeutics; Imaxio SA - Pipeline Overview and Promising Molecules; Imaxio SA - News; Imaxio SA - Latest Updates; Imaxio SA - Pipeline; Imaxio SA - Discontinued/Dormant Projects

Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]